{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/61428033"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The reduction in breast cancer mortality is mainly due to three factors: the widespread use of tamoxifen (which inhibits the influences of estrogen), the development and use of Herceptin (which is a monoclonal antibody that interferes with the HER2/neu receptor, thus selectively inhibiting the growth of breast cancer cells in about 25% of breast tumors) a" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "mdpi.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/462219672"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/61428033"] } } }
